Tyco/C.R.Bard
This article was originally published in The Gray Sheet
Executive Summary
Ongoing discussions with the Federal Trade Commission regarding Tyco's pending acquisition of Bard under a $3.2 bil. May deal will delay completion, which is now not expected before the first quarter of 2002, Bard says. The merger, which had been expected to close by year-end, likely has drawn scrutiny of overlap in the urology field, mainly in areas such as Foley catheters, and could result in a possible divestiture of part of the business...